Favorable/Unfavorable risk indicator-Favorable Posts on Medivizor
Navigation Menu

Favorable/Unfavorable risk indicator-Favorable Posts on Medivizor

How common is blood clotting in patients with Hodgkin’s lymphoma?

How common is blood clotting in patients with Hodgkin’s lymphoma?

Posted by on Aug 8, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This study investigated how often patients Hodgkin’s lymphoma (HL) experienced blood clots and what factors increased the risk of blood clots.  The authors found that patients with advanced HL were more likely to develop blood clots, particularly during chemotherapy, and that age, smoking status, and treatment frequency increased...

Read More

All hands on deck: leaving out chemotherapies from the ABVD regimen can decrease effectiveness

All hands on deck: leaving out chemotherapies from the ABVD regimen can decrease effectiveness

Posted by on Dec 20, 2016 in Hodgkin's lymphoma | 0 comments

In a nutshell This study examined whether the number of chemotherapy agents in the combination ABVD could be reduced when treating Hodgkin lymphoma. The authors concluded that to be effective all four chemotherapies need to be included. Some background More than 80% of patients with early-stage, favorable Hodgkin lymphoma experience long-term...

Read More
ABOUT USHOW IT WORKSBLOG NEWS PARTNERS CONTACT US PRIVACY POLICY TERMS OF USE
FROM OUR BLOG
LATEST NEWS
CONNECT WITH US
© 2024 Medivizor